Catherine M Stein Selected Research

Silver Sulfadiazine (SSD)

11/2021	Psychosocial Comorbidities in Adolescents With Histories of Childhood Apraxia of Speech.
7/2021	Association between genes regulating neural pathways for quantitative traits of speech and language disorders.
11/2019	Differential Long-Term Outcomes for Individuals With Histories of Preschool Speech Sound Disorders.
7/2018	Heritability and longitudinal outcomes of spelling skills in individuals with histories of early speech and language disorders.
5/2016	Psychosocial co-morbidities in adolescents and adults with histories of communication disorders.
5/2015	Adolescent outcomes of children with early speech sound disorders with and without language impairment.
10/2014	Association between AVPR1A, DRD2, and ASPM and endophenotypes of communication disorders.
10/2013	Reading skills of students with speech sound disorders at three stages of literacy development.
9/2012	Speech-Sound Disorders and Attention-Deficit/Hyperactivity Disorder Symptoms.
12/2011	Literacy outcomes of children with early childhood speech sound disorders: impact of endophenotypes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catherine M Stein Research Topics

Disease

18	Infections 01/2022 - 02/2007
16	Tuberculosis (Tuberculoses) 10/2022 - 06/2003
15	Speech Sound Disorder 11/2021 - 02/2004
4	Genetic Predisposition to Disease (Genetic Predisposition) 05/2011 - 11/2006
3	Dyslexia (Alexia) 05/2016 - 02/2004
3	Obesity 09/2009 - 12/2003
2	Apraxias (Dyspraxia) 11/2021 - 07/2018
2	Pulmonary Tuberculosis 01/2019 - 01/2014
2	Inflammation (Inflammations) 06/2017 - 09/2009
2	HIV Infections (HIV Infection) 06/2017 - 12/2015
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 05/2016 - 09/2012
2	Disease Progression 12/2015 - 02/2007
2	Communication Disorders (Communication Disorder) 10/2014 - 12/2006
1	Sarcoidosis (Schaumann Disease) 10/2022
1	Neurodevelopmental Disorders 07/2021
1	Hypersensitivity (Allergy) 01/2021
1	Speech Disorders (Cluttering) 11/2019
1	Latent Tuberculosis 01/2017
1	Hemorrhage 01/2016
1	Gingival Recession 01/2016
1	Periodontal Diseases (Periodontal Disease) 01/2016
1	Meningoencephalitis 03/2015
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 03/2015
1	Cicatrix (Scar) 03/2015
1	Microcephaly 10/2014
1	Communicable Diseases (Infectious Diseases) 01/2012
1	Disease Susceptibility (Diathesis) 05/2011
1	Hyperlipidemias (Hyperlipidemia) 12/2009
1	Insulin Resistance 09/2009
1	Non-alcoholic Fatty Liver Disease 09/2009
1	Language Disorders (Language Disorder) 12/2006
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 11/2006
1	Autistic Disorder (Autism) 11/2006
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2003
1	Hypertension (High Blood Pressure) 12/2003
1	Type 2 Diabetes Mellitus (MODY) 12/2003

Drug/Important Bio-Agent (IBA)

15	Silver Sulfadiazine (SSD)FDA LinkGeneric 11/2021 - 02/2004
14	Tuberculin (PPD)IBA 01/2022 - 01/2008
4	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 01/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2005
4	CytokinesIBA 01/2021 - 06/2003
3	InterferonsIBA 01/2021 - 01/2019
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016 - 02/2007
3	Triglycerides (Triacylglycerol)IBA 12/2009 - 12/2003
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 05/2011
2	VaccinesIBA 01/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 07/2017 - 10/2014
2	Glucose (Dextrose)FDA LinkGeneric 12/2003 - 12/2003
1	HLA-DRB1 Chains (HLA DRB1)IBA 10/2022
1	RGFP966IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 07/2017
1	Interleukin-9 (Interleukin 9)IBA 06/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	Interleukin-12 (IL 12)IBA 03/2016
1	DefensinsIBA 01/2016
1	Chemokine ReceptorsIBA 12/2015
1	LigandsIBA 12/2015
1	Retinaldehyde (Retinal)IBA 03/2015
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 10/2014
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 10/2014
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2014
1	AntigensIBA 04/2012
1	Cathepsin ZIBA 05/2011
1	LipidsIBA 12/2009
1	oxidized low density lipoproteinIBA 12/2009
1	AdiponectinIBA 09/2009
1	Alanine Transaminase (SGPT)IBA 09/2009
1	AdipokinesIBA 09/2009
1	HDL LipoproteinsIBA 09/2009
1	LeptinIBA 09/2009
1	Mycobacterium tuberculosis antigensIBA 01/2008
1	Toll-Like Receptor 9IBA 02/2007
1	A-factor (Streptomyces)IBA 03/2006
1	Leptin ReceptorsIBA 09/2004
1	HDL CholesterolIBA 12/2003

Therapy/Procedure

3	Therapeutics 03/2016 - 01/2014
1	Chemoprevention 01/2019
1	Aftercare (After-Treatment) 01/2014